α-Fetoprotein in malignant germ cell tumors of the ovary
- 30 November 1990
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 39 (2), 160-166
- https://doi.org/10.1016/0090-8258(90)90425-k
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education
This publication has 18 references indexed in Scilit:
- Study of ovarian tumors treated at Nagoya University Hospital, 1965–1988Gynecologic Oncology, 1990
- Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vincristine, dactinomycin, and cyclophosphamideCancer, 1985
- Vinblastine, bleomycin, and cisplatin in malignant germ cell tumors of the ovaryCancer, 1985
- Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary. A gynecologic oncology group study (a final report)Cancer, 1985
- Reactivity of a monoclonal antibody with human ovarian carcinoma.JCI Insight, 1981
- Serum alphafetoprotein (AFP) in patients with germ cell tumors of the gonads and extragonadal sites: Correlation between endodermal sinus (yolk sac) tumor and raised serum AFPCancer, 1980
- Endodermal sinus tumor of the ovary.A clinical and pathologic analysis of 71 casesCancer, 1976
- Advances in chemotherapy for gynecologic cancerCancer, 1975
- Alpha-fetoprotein and endodermal sinus tumor of the ovaryAmerican Journal of Obstetrics and Gynecology, 1973
- Solid teratoma of the ovary.A clinicopathological analysis of 9 casesCancer, 1960